Recombinant Bovine Receptor expression-enhancing protein 4 (REEP4)

What is Receptor Expression-Enhancing Protein 4 (REEP4) and what is its primary cellular localization?

Receptor Expression-Enhancing Protein 4 (REEP4) is a member of the REEP family of proteins characterized by the presence of a reticulon homology domain (RHD). REEP4 is predominantly localized in the cytosol and nucleoplasm, with significant presence in the endoplasmic reticulum (ER) where it contributes to membrane curvature . Recent research has also identified REEP4 at the inner nuclear membrane (INM), suggesting a more complex distribution than previously understood . The protein plays critical roles in membrane morphology, particularly during cell division where it helps maintain the tubular structure of the mitotic ER. This localization pattern makes REEP4 an important factor in cellular processes requiring membrane remodeling.

How does the structure of REEP4 contribute to its function in membrane curvature?

REEP4's ability to influence membrane curvature stems from its reticulon homology domain (RHD), which contains hydrophobic segments that can insert into the lipid bilayer. The RHD works as a wedge in the outer leaflet of the membrane, creating and stabilizing areas of high curvature . Experimental evidence shows that the N-terminal RHD is essential for REEP4's function in promoting ER tubulation. Chimeric experiments involving REEP2 and REEP4 have demonstrated that while the RHD is necessary, the C-terminal region of REEP4 contains regulatory sequences that coordinate with the RHD to effectively generate high-curvature ER structures during mitosis . This structural arrangement allows REEP4 to shape membranes in both the peripheral ER and, as recent studies suggest, at the nuclear envelope during nuclear pore complex assembly.

What are the experimental approaches commonly used to study REEP4 expression and localization?

Research on REEP4 typically employs a combination of molecular and cellular techniques. For expression analysis, quantitative PCR (qPCR) and Western blotting are standard methods to measure mRNA and protein levels, respectively. In the context of cancer research, these techniques have revealed significant upregulation of REEP4 in kidney clear cell carcinoma (KIRC) compared to normal tissues .

For localization studies, immunofluorescence microscopy with specific antibodies against REEP4 is commonly used to visualize its distribution. Additionally, fusion proteins with fluorescent tags (such as GFP or HA-tags) allow for live-cell imaging and co-localization experiments. Researchers also employ subcellular fractionation to biochemically separate cellular compartments and confirm localization patterns .

More sophisticated approaches include proximity labeling methods (such as BioID or APEX) to identify proteins interacting with REEP4 in specific cellular compartments, providing insights into its functional networks.

How does REEP4 contribute to endoplasmic reticulum morphology during mitosis?

REEP4, along with its homolog REEP3, plays a crucial role in maintaining the highly curved tubular morphology of the endoplasmic reticulum (ER) during cell division. During mitosis, the ER undergoes dramatic reorganization, and REEP3/4 proteins are specifically required for generating and maintaining the high-curvature structures necessary for proper ER function during this process .

Depletion experiments demonstrate that when REEP3 and REEP4 are simultaneously knocked down, cells fail to maintain proper ER morphology during mitosis, resulting in sheet-like ER structures rather than the normal tubular network. This phenotype can be rescued by reintroducing wild-type REEP4, but not by constructs lacking functional reticulon homology domains . Interestingly, while other REEP family members (like REEP2) contain similar RHDs, they cannot substitute for REEP4 during mitosis, indicating that REEP4 has specific regulatory sequences in its C-terminal region that coordinate with the RHD to promote proper ER tubulation during cell division.

What is the role of REEP4 in nuclear pore complex assembly?

Recent research has uncovered an unexpected role for REEP4 in nuclear pore complex (NPC) assembly. REEP4 is recruited to the inner nuclear membrane by the NPC biogenesis factor ELYS, where it promotes the assembly of nuclear pore complexes . This function is particularly significant during anaphase, when the nuclear envelope reforms after mitosis.

REEP4's contribution to post-mitotic NPC assembly likely stems from its ability to create membrane curvature, which is necessary for the formation of nuclear pores. The protein appears to coordinate nuclear envelope reformation with NPC biogenesis, ensuring that newly formed nuclei have functional transport channels. Experimental approaches to study this function include live-cell imaging of fluorescently tagged REEP4 during mitosis, immunoprecipitation to detect interactions with NPC components, and electron microscopy to visualize the ultrastructure of nuclear pores in cells with altered REEP4 expression .

What techniques are used to investigate REEP4's dynamics during the cell cycle?

Investigating REEP4's behavior throughout the cell cycle requires sophisticated live-cell imaging techniques. Researchers typically create stable cell lines expressing fluorescently tagged REEP4 (such as REEP4-GFP) and track its localization and dynamics using time-lapse confocal microscopy. This approach allows visualization of REEP4's redistribution during different cell cycle phases, particularly during mitosis.

To synchronize cells at specific cell cycle stages, researchers employ chemical treatments (such as thymidine block for G1/S boundary or nocodazole for prometaphase arrest) followed by release, allowing for targeted observation of REEP4 behavior at precise timepoints. Flow cytometry can confirm the cell cycle distribution of the population.

For more precise temporal control, optogenetic approaches have been developed to rapidly inactivate or relocalize REEP4 at specific cell cycle stages, enabling detailed analysis of its functions. Complementing these approaches, FRAP (Fluorescence Recovery After Photobleaching) experiments provide insights into REEP4's mobility and turnover rates in different cellular compartments throughout the cell cycle.

How is REEP4 expression altered in kidney clear cell carcinoma (KIRC) and what are the clinical implications?

REEP4 expression is significantly upregulated in kidney clear cell carcinoma (KIRC) tumor tissues compared to normal kidney tissues. This increased expression positively correlates with tumor malignancy - higher levels of REEP4 are associated with advanced tumor stage, including WHO stage, T stage, N stage, and M stage . The clinical data also shows racial differences in REEP4 expression patterns among KIRC patients (p=0.003), though no significant disparities were observed between sexes.

What experimental protocols are recommended for assessing REEP4 as a cancer biomarker?

When evaluating REEP4 as a potential cancer biomarker, researchers should implement a multi-level assessment approach. Initially, REEP4 expression should be quantified at both mRNA and protein levels in matched tumor and adjacent normal tissues. For mRNA analysis, RT-PCR and RNA sequencing provide comprehensive expression profiles. At the protein level, immunohistochemistry on tissue microarrays allows for visualization of REEP4 distribution patterns across multiple patient samples simultaneously, while Western blotting provides quantitative measurements.

For clinical correlation studies, detailed patient data including tumor stage, grade, and follow-up information should be collected. Statistical analyses including Kaplan-Meier survival curves, univariate and multivariate Cox regression analyses must be performed to evaluate the prognostic significance of REEP4 expression. The development of a standardized scoring system for REEP4 expression is crucial for reproducibility across different laboratories and clinical settings .

To validate REEP4's functional relevance, in vitro experiments in relevant cell lines (such as renal cancer cells) should include REEP4 knockdown or overexpression followed by proliferation, migration, and invasion assays. Additionally, mouse xenograft models can provide in vivo validation of REEP4's impact on tumor growth and metastasis.

How does REEP4 expression influence immunotherapy outcomes in cancer patients?

Tumor Immune Dysfunction and Exclusion (TIDE) score analysis demonstrated that patients with low REEP4 expression had significantly decreased TIDE scores compared to those with high expression (p<0.0001). Additionally, T cell dysfunction was less pronounced in the low-expression group (p<0.0001), although no notable difference was observed in T-cell exclusion scores between the groups . These findings suggest that high REEP4 expression may increase the risk of immune evasion and consequently reduce immunotherapeutic success.

Drug sensitivity studies using the CellMiner database indicated that REEP4 expression positively correlates with sensitivity to specific anticancer drugs like quizartinib and SNS-314, suggesting that patients with high REEP4 expression might benefit from these treatments. Conversely, certain immunotherapeutic drugs including dasatinib and pluripotin showed negative correlation with REEP4 expression levels, indicating they may be less effective for patients with high REEP4 expression .

What signaling pathways and protein interactions are associated with REEP4 function?

REEP4 functions through several key signaling pathways and protein interactions critical to cellular processes. Gene function analysis has identified significant associations between REEP4 and cell cycle regulation pathways, with particular involvement in protein binding interactions . As a membrane-shaping protein, REEP4 interacts with lipid bilayers through its reticulon homology domain (RHD), which facilitates the creation of membrane curvature.

In the context of nuclear pore complex (NPC) assembly, REEP4 interacts directly with the NPC biogenesis factor ELYS, which recruits REEP4 to the inner nuclear membrane . This interaction is essential for coordinating nuclear envelope reformation with post-mitotic NPC biogenesis. The temporal regulation of this process suggests involvement of cell cycle-dependent kinases and phosphorylation events, though specific regulatory mechanisms require further investigation.

REEP4's homology and functional overlap with REEP3 indicate shared interaction networks, particularly in the context of endoplasmic reticulum membrane shaping during mitosis . The specificity of REEP4 function during mitosis (compared to other REEP family members) points to unique protein interactions mediated by its C-terminal regulatory regions that coordinate with the RHD to promote proper membrane tubulation during cell division.

How do experimental models for studying REEP4 differ between in vitro and in vivo approaches?

The study of REEP4 employs diverse experimental models that offer complementary insights into its function. In vitro approaches typically utilize cell culture systems, including both cancer cell lines and primary cells. These systems allow for precise genetic manipulation through RNA interference, CRISPR-Cas9 genome editing, or overexpression studies to modulate REEP4 levels. Cell lines are particularly valuable for live imaging of fluorescently tagged REEP4, enabling real-time visualization of its dynamics during processes like cell division .

Biochemical approaches in vitro include protein purification for structural studies and reconstitution experiments with artificial membrane systems to directly observe REEP4's membrane-shaping capabilities. These controlled environments permit detailed mechanistic studies but may not fully recapitulate the complex physiological context.

In vivo models, primarily utilizing mouse systems, provide crucial insights into REEP4's physiological roles. Knockout or conditional knockout mouse models for REEP4 help evaluate its function during development and in tissue-specific contexts. Xenograft models using human cancer cells with modified REEP4 expression enable assessment of its role in tumor formation and progression in a more physiologically relevant environment .

Each approach has distinct advantages: in vitro systems offer precise control and detailed mechanistic studies, while in vivo models provide physiological relevance and systemic effects. Integrating data from both approaches provides the most comprehensive understanding of REEP4 biology.

What methodological challenges exist in studying the membrane-shaping properties of REEP4?

Investigating REEP4's membrane-shaping properties presents several technical challenges that researchers must address. First, the dynamic nature of membrane remodeling requires sophisticated live imaging techniques with sufficient temporal and spatial resolution to capture rapid changes in membrane morphology. Super-resolution microscopy techniques such as structured illumination microscopy (SIM) or stimulated emission depletion (STED) microscopy have improved visualization of membrane structures, but still face limitations in temporal resolution.

The structural analysis of membrane-associated proteins like REEP4 is particularly challenging due to their hydrophobic domains. Traditional structural biology approaches such as X-ray crystallography often struggle with membrane proteins, necessitating alternative approaches like cryo-electron microscopy or nuclear magnetic resonance spectroscopy. Even with these methods, capturing REEP4 in its native membrane environment remains difficult.

In vitro reconstitution systems using purified components and artificial membranes allow for controlled studies of REEP4's membrane-shaping capabilities, but may not fully replicate the complex lipid composition and protein interactions present in cellular membranes. Researchers must carefully design these systems to include physiologically relevant membrane compositions.

Additionally, distinguishing the specific contribution of REEP4 from other membrane-shaping proteins presents a challenge, as cells express multiple proteins with similar functions. Developing selective inhibitors or acute inactivation methods for REEP4 would significantly advance research in this area.

How might recombinant REEP4 protein be utilized in therapeutic applications?

The potential therapeutic applications of recombinant REEP4 protein stem from its roles in membrane remodeling and its association with cancer progression. For cancer therapeutics, particularly in kidney clear cell carcinoma where REEP4 is overexpressed, approaches targeting REEP4 could be developed. These might include blocking antibodies against REEP4, small molecule inhibitors that disrupt its function, or RNA interference-based therapies to reduce its expression .

Given REEP4's role in immunotherapy responses, it could serve as a predictive biomarker to stratify patients for treatment with PD-1 inhibitors alone or in combination with CTLA4 inhibitors. Patients with low REEP4 expression might benefit more from immunotherapy approaches, while those with high expression might require alternative strategies .

Beyond cancer, recombinant REEP4 protein might have applications in cell biology research and regenerative medicine. Its membrane-shaping properties could be harnessed to engineer artificial cellular structures or to enhance nuclear envelope reformation in cellular reprogramming contexts. Additionally, understanding REEP4's role in nuclear pore complex assembly could inform approaches to modulate nucleocytoplasmic transport in disease states where this process is dysregulated .

What are the latest technical advancements in producing and purifying recombinant REEP4?

Production of high-quality recombinant REEP4 presents challenges due to its membrane-associated domains. Recent technical advancements have improved yield and purity through specialized expression systems. While bacterial expression systems (particularly Escherichia coli) remain common for cost-effectiveness and scalability, membrane proteins like REEP4 often benefit from eukaryotic expression systems such as insect cells (Sf9 or High Five) or mammalian cells that provide appropriate post-translational modifications and membrane environments.

Purification strategies have evolved to include specialized detergents and nanodiscs that maintain REEP4's native conformation. Mild detergents like n-dodecyl-β-D-maltoside (DDM) or digitonin help extract REEP4 from membranes while preserving its structure. Affinity tags such as polyhistidine or FLAG tags facilitate initial purification, followed by size exclusion chromatography and ion exchange techniques for increased purity.

Quality control protocols for recombinant REEP4 now routinely include functional assays to verify membrane-binding activity, typically using liposome tubulation assays or electron microscopy to confirm the protein's ability to induce membrane curvature. Thermal shift assays and circular dichroism spectroscopy help assess protein stability and secondary structure, ensuring the recombinant protein maintains native-like properties essential for experimental applications.

What emerging research questions about REEP4 remain to be addressed?

Despite significant advances in understanding REEP4 function, several critical research questions remain unanswered. Perhaps most fundamental is elucidating the precise molecular mechanism by which REEP4 generates membrane curvature during specific cellular processes like mitosis. While its reticulon homology domain (RHD) is known to be essential, the exact structural changes and lipid interactions that occur during membrane remodeling need further characterization .

The regulatory mechanisms controlling REEP4 activity throughout the cell cycle remain poorly understood. Identifying the kinases, phosphatases, and other post-translational modifications that modulate REEP4 function would provide insights into how its membrane-shaping activity is precisely timed during mitosis and nuclear envelope reformation .

REEP4's unexpected role in nuclear pore complex assembly raises questions about potential additional functions at the nuclear envelope. Whether REEP4 interacts with other nuclear envelope proteins beyond ELYS or contributes to other aspects of nuclear architecture remains to be explored .

In the context of cancer, mechanistic studies are needed to understand how REEP4 overexpression contributes to tumor progression. Does REEP4 directly influence cell proliferation and invasion, or does its effect operate through alterations in membrane dynamics that impact signaling pathways? Additionally, exploring REEP4's role in metastasis would be valuable, given the higher expression observed in cases with distant metastases .

Finally, the potential functional redundancy and compensation between REEP family members merits investigation. While REEP3 can partially compensate for REEP4 loss, other family members cannot . Understanding these specific functional differences could provide deeper insights into the specialized roles of REEP proteins in membrane biology.